EFFICACY OF A NOVEL ANTIBODY-DRUG CONJUGATE (ADC), ABT-414, AS MONOTHERAPY IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED, RECURRENT GLIOBLASTOMA (GBM) Conference Paper uri icon

authors

  • van den Bent, M
  • Gan, HK
  • Lassman, AB
  • Kumthekar, P
  • Butowski, N
  • Lwin, Z
  • Nabors, LB
  • Simes, J
  • Holen, K
  • Reardon, DA

publication date

  • October 1, 2016